First Trust Nasdaq Pharmaceuticals ETF (FTXH) — ETF Analysis on Winston
Key Facts
- Issuer: First Trust
- Asset Class: Stock
- Price: $42.26
- Expense Ratio: 60.00%
- Assets Under Management: $68M
- Number of Holdings: 51
- Inception Date: 2016-09-20
- Currency: USD
Winston Score
First Trust Nasdaq Pharmaceuticals ETF has a Winston Score of 60 out of 100.
Performance
- 1-Year Return: 32.28%
- 3-Year Return: 27.57%
- 5-Year Return: 28.94%
Top Holdings
Eli Lilly and Company (N/A%), AbbVie Inc. (N/A%), Merck & Co., Inc. (N/A%), Johnson & Johnson (N/A%), Bristol-Myers Squibb Company (N/A%)
Sector Breakdown
Healthcare (N/A%)